FDA Approved: KORSUVA — Supplemental Application (Vifor (International), Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Korsuva (difelikefalin) submitted by Vifor International, Inc., updating/expanding its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease-associated Pruritus

Drugs mentioned

• KORSUVA (Difelikefalin)

Snippet

SUPPL AP for KORSUVA (DIFELIKEFALIN)